Trials / Completed
CompletedNCT00770900
Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)
Prospective, Randomized, Double-blind, Study to Evaluate the Eosinophils Activation Parameters and Phagocyte Function in Patients With Persistent Asthma Treated With Montelukast
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 83 (actual)
- Sponsor
- University of Brasilia · Academic / Other
- Sex
- All
- Age
- 2 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Verify if the quantitative parameters of the eosinophils activation and phagocyte system function show a predictive value for clinical response and prognostic in patients with persistent asthma treated with montelukast
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast sodium | Asthmatic children and teenagers took montelukast daily for 12 weeks. Children aged 2-5 years took 4mg tablet of montelukast Children aged 6-15 years took 5mg tablet of montelukast Children \>15 years took 10mg tablet of montelukast |
| DRUG | Comparator: placebo comparator | Asthmatic children and teenagers took Placebo tablet daily for 12 weeks. |
Timeline
- Start date
- 2008-09-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2008-10-10
- Last updated
- 2010-12-20
Source: ClinicalTrials.gov record NCT00770900. Inclusion in this directory is not an endorsement.